|
M
Mon
|
T
Tue
|
W
Wed
|
T
Thu
|
F
Fri
|
S
Sat
|
S
Sun
|
|---|---|---|---|---|---|---|
|
0 events,
|
0 events,
|
0 events,
|
0 events,
|
0 events,
|
0 events,
|
0 events,
|
|
0 events,
|
1 event,
-
Dr. Tilo Kunath discussed his work on characterizing clinical grade stem cells so they can be used for patient therapies. We talked to Tilo about his past and current work, including his latest paper published in Scientific Reports. Don’t miss Tilo’s funny story! |
0 events,
|
0 events,
|
0 events,
|
0 events,
|
0 events,
|
|
0 events,
|
0 events,
|
0 events,
|
0 events,
|
0 events,
|
0 events,
|
0 events,
|
|
0 events,
|
1 event,
-
Scott Dylla, CSO and co-founder of Stemcentrx, a really cool new company that is using novel technology to target stem cells as a therapy for different cancers, joined us for this interview. |
0 events,
|
0 events,
|
0 events,
|
0 events,
|
0 events,
|
|
0 events,
|
0 events,
|
0 events,
|
0 events,
|
0 events,
|
0 events,
|
0 events,
|
